NCT05747573View on ClinicalTrials.gov

A Study to Compare Pharmacokinetics of GB1211

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

April 10, 2023

Study Completion Date

April 10, 2023

Conditions

Pharmacokinetics

Interventions

DRUG

GB1211

Hard tablet or capsules for oral use

Trial Locations (1)

9713

QPS Netherlands BV, Groningen

Sponsors

Lead Sponsor

Galecto Biotech AB

All Listed Sponsors

collaborator

QPS Holdings LLC

INDUSTRY

lead

Galecto Biotech AB

INDUSTRY

NCT05747573 - A Study to Compare Pharmacokinetics of GB1211 | Biotech Hunter | Biotech Hunter